Trial · NCT03298867
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Masked 24-Week Treatment Period | STARTED | Placebo | 42 | |
| Double-Masked 24-Week Treatment Period | STARTED | Teprotumumab 20 mg/kg | 41 | |
| Double-Masked 24-Week Treatment Period | COMPLETED | Placebo | 40 | |
| Double-Masked 24-Week Treatment Period | COMPLETED | Teprotumumab 20 mg/kg | 39 | |
| Double-Masked 24-Week Treatment Period | NOT COMPLETED | Placebo | 2 | |
| Double-Masked 24-Week Treatment Period | NOT COMPLETED | Teprotumumab 20 mg/kg | 2 | |
| 48-Week Follow-Up Period (Weeks 24-72) | STARTED | Placebo | 4 | |
| 48-Week Follow-Up Period (Weeks 24-72) | STARTED | Teprotumumab 20 mg/kg | 36 | |
| 48-Week Follow-Up Period (Weeks 24-72) | COMPLETED | Placebo | 3 | |
| 48-Week Follow-Up Period (Weeks 24-72) | COMPLETED | Teprotumumab 20 mg/kg | 20 | |
| 48-Week Follow-Up Period (Weeks 24-72) | NOT COMPLETED | Placebo | 1 | |
| 48-Week Follow-Up Period (Weeks 24-72) | NOT COMPLETED | Teprotumumab 20 mg/kg | 16 | |
| 48-Week Follow-Up Contact (Weeks 96-120) | STARTED | Placebo | 3 | |
| 48-Week Follow-Up Contact (Weeks 96-120) | STARTED | Teprotumumab 20 mg/kg | 20 | |
| 48-Week Follow-Up Contact (Weeks 96-120) | COMPLETED | Placebo | 3 | |
| 48-Week Follow-Up Contact (Weeks 96-120) | COMPLETED | Teprotumumab 20 mg/kg | 19 | |
| 48-Week Follow-Up Contact (Weeks 96-120) | NOT COMPLETED | Placebo | 0 | |
| 48-Week Follow-Up Contact (Weeks 96-120) | NOT COMPLETED | Teprotumumab 20 mg/kg | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03298867/flow